|
1970
- 1980
|
|
|
1981
- 1990
|
|
|
1991
- 2000
|
|
| Band 4 | 2001 - 2010 |
| Band 5 | 2011 - 2014 |
| Band 6 | 2015 - 2017 |
|
Band
5 |
|
| 2011. | |
| 231. |
Kaden, J. Intraoperative Hochdosis-Induktion mit ATG-Fresenius MedReport 2011; 35: 8 |
| 232. |
Kaden J., G.May, A.Völp, C.Wesslau Efficacy and Safety of the Intra-operative High-dose Induction with ATG-Fresenius in Older Kidney Graft Recipients. Tx Med 2011; 23: 215-222 |
| 233. |
Kaden J., G.May, A.Völp, C.Wesslau Factors impacting short and long-term kidney graft survival: Modification by single intra-operative high-dose induction with ATG-Fresenius Ann Transplant 2011; 16(4): 81-91 |
| 234. | Kaden J., G.May, A.Völp, C.Wesslau The Intra-operative High-dose Induction with ATG-Fresenius in Elderly Kidney Graft Recipients is as Efficient and Safe as in Younger Recipients (Abstract) Transplant Int 2011; 24 (Suppl. 3): 49 |
| 2012. | |
| 235. | Kaden J. Buchbesprechung: Walter Gottlieb Land, Innate Alloimmunity. Part 1: Innate Immunity and Host Defense, Baskent University/Pabst Science Publishers, 2009, ISBN-978-975-7692-61-4 Transplantationsmedizin 2012; 24: 79-80 |
| 236. | Kaden J. Buchbesprechung: Walter Gottlieb Land, Innate Alloimmunity. Part 2: Innate Immunity and Allograft Rejection, Baskent University/Pabst Science Publishers, 2011, ISBN-978-975-8571-49-9 Transplantationsmedizin 2012; 24: 81-82 |
237. |
Abendroth D.K., M. Marzinzig, J. Kaden, M.J. Stangl, M. Raggi Acute rejection as key predictor for long-term outcomes after kidney transplantation. 24th Int Congr of the Transplantion Society (Abstract). July 15-19, 2012, Berlin, Germany, www.transplantjournal.com |
| 2013. | |
| 238. |
Kaden J., Regelwidrige Transplantationen: Ubi pus, ibi evacua. Transplantation.de, 09.01.2013 |
| 239. | Kaden J., A. Völp, C. Wesslau High graft protection and low incidences of infections, malignancies and other adverse effects with intraoperative high dose ATG-induction: A single centre cohort study of 760 cases. Ann Transplant, 2013: 18: 9-22, DOI: 10.12659/AOT.883792 |
| 240. | Kaden J., A. Völp, C. Wesslau Re-treatment by ATG-Fresenius for kidney graft rejection: Safety and efficacy. Transplantationsmedizin, Transplantationsmedizin 2013;25:3-11 |
| 241. | J. Kaden, D. Abendroth, A. Völp, M. Marzinzig. Impact of pre-sensitization, time on waiting list and haemodialysis on pre-transplant as well as of graft function on post-transplant serum kynurenine level in kidney graft recipients (Abstract) Transplant Int 26, Suppl. 1(2013), 30 |
| 242. | J. Kaden, D. Abendroth, A. Völp, M. Marzinzig: |
| 243. | J. Kaden, D. Abendroth, A. Völp, M. Marzinzig, C. Wesslau: |
| 2014 | |
| 244. | J. Kaden, D. Abendroth, A. Völp, M. Marzinzig, C. Wesslau: |
| 245. | J. Kaden, D. Abendroth, A. Völp, M.
Marzinzig Kynurenine as an early marker for complications after renal transplantation Transplant Int, 2014; 27 (Suppl. 3): 26 |
| 246. | Abendroth D., M. Marzinzig, J. Kaden Activation of innate immunity in the donor and relation to induction treatment. Transplant Int, 2014; 27 (Suppl. 3): 27 |
| 247. | J. Kaden, D. Abendroth, A. Völp, M.
Marzinzig Kynurenin – ein zuverlässiger Parameter zur Erkennung drohender Komplikationen nach Nierentransplantation. Poster, Kongress der Deutschen Transplantationsgesellschaft, Mannheim, 16.-18.10.2014 |
| 248. | J. Kaden, A. Völp, M.
Marzinzig, D. Abendroth Diagnostic relevance of kynurenine serum levels in kidney graft recipients. Poster, World Transplant Congress, San Francisco, July 26-31, 2014 |
| 249. |
Abendroth D., M. Marzinzig, J. Kaden, M. Stangl |
2015 |
|
| 250. |
Jürgen Kaden, Dietmar Abendroth, Andreas Völp,
Michael Marzinzig, |
| 251. |
Jürgen Kaden, Dietmar Abendroth, Andreas Völp,
Michael Marzinzig, |
| 252. |
Jürgen Kaden, Dietmar Abendroth, Andreas Völp,
Michael Marzinzig, |
|
1970
- 1980
|
|
|
1981
- 1990
|
|
|
1991
- 2000
|
|
| Band 4 | 2001 - 2010 |
| Band 5 | 2011 - 2014 |
| Band 6 | 2015 - 2017 |